<DOC>
	<DOCNO>NCT00713622</DOCNO>
	<brief_summary>Zonisamide ( Zonegran ) sodium valproate ( Epilim ) medicine approve treat epilepsy . The purpose study find extent zonisamide may affect memory concentration , compare sodium valproate .</brief_summary>
	<brief_title>Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate</brief_title>
	<detailed_description>Zonisamide ( Zonegran ) sodium valproate ( Epilim ) medicine approve treat epilepsy . The purpose study find extent zonisamide may affect memory concentration , compare sodium valproate . This investigated use cognitive test perform computer screen . Either zonisamide sodium valproate add second medicine one patient currently take , carbamazepine ( Tegretol ) , continue throughout study . It plan 80 people across Europe take part study . For purpose study , patient need go study doctor 's clinic 4 time 5 telephone call . Involvement study might long 20 week , could short 12 week . The length study number visit depend whether patient accurate record previous seizure already , many seizure study , whether decide continue stop treatment study complete . Adult subject clinical diagnosis non-symptomatic ( i.e. , idiopathic unknown cause ) localisation-related epilepsy , partial onset seizure without secondary generalisation , receive fix dose carbamazepine therapy transfer carbamazepine ( therapy ) two month study baseline . Subjects must require addition another anti-epileptic drug ( AED ) anti-epileptic therapy , either continue seizure ( i.e. , control ) , wish switch another AED reason ( e.g. , tolerate another drug well ) .</detailed_description>
	<mesh_term>Zonisamide</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Inclusion criterion : 1 . Subjects clinical diagnosis nonsymptomatic ( i.e. , idiopathic cryptogenic ) localisationrelated epilepsy partial onset seizure without secondary generalisation accord International League Against Epilepsy ( ILAE ) classification27 . Diagnosis clinically establish history , previous electroencephalogram ( EEG ) previous magnetic resonance image computer tomography brain , consistent localisation relate epilepsy . No low upper limit baseline seizure define . 2 . Able willing sign inform consent form ( ICF ) accordance International Conference Harmonisation ( ICH ) Good Clinical Practice ( GCP ) guideline . 3 . Male female subject age ≥18 year . 4 . Subjects take carbamazepine monotherapy baseline transfer carbamazepine monotherapy two month Screening Visit . Dose carbamazepine within recommended SPC . Carbamazepine dose alter previous 2 week prior start Baseline Period , 6 week Baseline Period shorten due availability retrospective seizure history . The carbamazepine dose remain stable throughout study . 5 . Subjects require addition another AED , either continue seizure ( refractory ) , wish eventually switch another AED reason study completion ( e.g . tolerability reason ) . 6 . Female subject childbearing potential must pregnant ( confirm negative serum betahuman chorionic gonadotropin ( βHCG ) screen negative urine pregnancy test baseline study ) , must lactate must use medically acceptable form contraception study least 1 month discontinuation study drug . Medically acceptable contraception define : High dose combine oral contraceptive ( OC ) pill ( 50µg oestrogen preparation ) Documented surgical sterilisation document vasectomised sexual partner Intrauterine device place least 3 month exceed documented replacement date . ( If replacement date available , device must situ 5 year ) . Women 2 year postmenopause Abstinence Examples contraception NOT acceptable include , limited : · Conventional dose combine OC ( &lt; 50µg oestrogen ) Progesteroneonly OC Contraceptive implant Contraceptive patch Progesterone injection Barrier contraception : Condom Diaphragm Sponge Exclusion criterion : 1 . Previous treatment valproate zonisamide . 2 . Use AED carbamazepine le 6 week prior randomisation , carbamazepine , zonisamide sodium valproate study . 3 . Hypersensitivity zonisamide valproate respective excipients . 4 . Predisposing condition potentially alter absorption , distribution elimination zonisamide valproate . 5 . Sulphonamide allergy . 6 . Subjects diagnose idiopathic/primary generalise epilepsy result clinical investigation EEG suggest idiopathic/primary generalise epilepsy . 7 . History status epilepticus within 12 month screen whilst comply AED therapy . 8 . History cluster seizure . 9 . History non epileptic seizure . 10 . Use benzodiazepines Baseline Period randomise treatment . 11 . Regular treatment antihistamine . 12 . Use ketogenic diet . 13 . Use acetazolamide , triamterene , vitamin C ( &gt; 2g/day ) , regular antacid medicine associate nephrolithiasis less one month prior randomisation study . 14 . Subjects vagal nerve stimulator implant , due implant within expect duration study . 15 . Subjects expect undergo surgery within expect duration study . 16 . History renal calculus renal insufficiency ( upper normal limit creatinine ) . 17 . Active psychiatric disease . 18 . History suicide attempt within last 2 year . 19 . History drug alcohol abuse within last 2 year . 20 . History cerebrovascular disease/stroke transient ischemic attack ; progressive neurological disease ; focal central nervous system pathology behavioural disturbance may impair subject 's ability complete neuropsychological test ; previous current brain neoplasm . 21 . Neoplastic disease within last 5 year except nonmetastatic adequately treat cutaneous squamous cell carcinoma . 22 . Diagnosis human immunodeficiency virus ( HIV ) Hepatitis B C. 23 . Other clinically significant organic disease . 24 . Female subject lactate , pregnant intend become pregnant . 25 . Subjects history demonstrate non compliance medication inability maintain seizure diary . 26 . Subjects consider Investigator within normal cognitive limit . 27 . Participation clinical study within 30 day screen . 28 . Clinically significant laboratory value abnormalities baseline . 29 . Weight &lt; 40kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Partial</keyword>
	<keyword>onset</keyword>
	<keyword>seizure</keyword>
</DOC>